Financial/Passive Investments
| Pharmaceuticals | Concept Development | Lead Discovery | Lead Optimization | Preclinical Development | Phase I | Phase II | Phase III | Launch | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pergamum AB (Laurantis Pharma Oy) (cis-UCA dermatology) |
|
|||||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
Pergamum AB (Laurantis Pharma Oy) (cis-UCA oncology) |
|
|||||||||||||||
Pergamum AB (Laurantis Pharma Oy) (ad-VEGF-C) |
|
|||||||||||||||
|
|
||||||||||||||||
BioArctic Neuroscience ABBioArctic Neuroscience develops new treatment methods and diagnostic tools for Alzheimer’s disease and other neurodegenerative diseases. www.bioarctic.se |
CytoGuide ApSCytoguide develops pharmaceuticals that selectively bind receptors on cells in inflamed tissue. www.cytoguide.dk |
Laurantis Pharma OyLaurantis Pharma develops new drugs against atopic dermatitis and cancer. www.pergamum.com |
||
NephroGenex Inc.NephroGenex is developing pharmaceuticals against certain kidney diseases. www.nephrogenex.com |
|
|